Endonovo Therapeutics Inc (ENDV)

[Tkmoney1]

You hit the nail on the head Craig. Nothing has really changed as far as diluting is concerned. In fact, it's even less than before when we were not in nearly as good as shape as we are in now. One of the big reasons I believe we shot up to .13 was the buildup to the initial heart trial results. It's always beneficial to have a known catalyst that people are looking for, to help drive the price and interest up. But as you've said we are in a quiet period now, with almost no news whatsoever for 2 months. Seems like we are poised to break out soon but understand the frustration everyone is having here.